Table 1.

Summary of Patients Treated

Patient	Condition	Route	Total Injected	Follow Up	Notable Events
AA	MS	IV & IT	16 million	12 months	None
PW	MS	IT	30 million	2 months	None
RH	MS	IT	30 million	2 months	None
JU	MS	IT	30 million	5 months	None